SCHEMBL22844489

SCHEMBL22844489

C[C@]12CCC(=O)CC1CC[C@@H]1C2CC[C@]2(C)C(=O)CCC12

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 5/20 1.00
AKR1B10 O60218 2/20 1.00
AKR1B1 P15121 2/20 1.00
OR51E2 Q9H255 1/20 1.00
GPBAR1 Q8TDU6 5/20 0.65
SHBG P04278 4/20 0.65
CYP3A4 P08684 4/20 0.65
SERPINA6 P08185 3/20 0.65
NR3C1 P04150 1/20 0.65
PGR P06401 1/20 0.65
NR3C2 P08235 1/20 0.65
AR P10275 1/20 0.65
HSD17B10 Q99714 1/20 0.65
MGAM O43451 1/20 0.65
MEN1 O00255 4/20 0.64
KMT2A Q03164 4/20 0.64
LMNA P02545 3/20 0.64
MAPK1 P28482 2/20 0.64
POLB P06746 1/20 0.64
HSD17B3 P37058 1/20 0.64

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL891363 1.00 CYP19A1 (1.00) CYP19A1AKR1B10AKR1B1OR51E2GPBAR1
SCHEMBL1114187 1.00 CYP19A1 (1.00) CYP19A1AKR1B10AKR1B1OR51E2GPBAR1
SCHEMBL15369324 1.00 CYP19A1 (1.00) CYP19A1AKR1B10AKR1B1OR51E2GPBAR1
SCHEMBL12394882 1.00 CYP19A1 (1.00) CYP19A1AKR1B10AKR1B1OR51E2GPBAR1
SCHEMBL868473 1.00 CYP19A1 (1.00) CYP19A1AKR1B10AKR1B1OR51E2GPBAR1
SCHEMBL16305624 1.00 CYP19A1 (1.00) CYP19A1AKR1B10AKR1B1OR51E2GPBAR1
SCHEMBL12377165 1.00 CYP19A1 (1.00) CYP19A1AKR1B10AKR1B1OR51E2GPBAR1
SCHEMBL868472 1.00 CYP19A1 (1.00) CYP19A1AKR1B10AKR1B1OR51E2GPBAR1
SCHEMBL15426613 1.00 CYP19A1 (1.00) CYP19A1AKR1B10AKR1B1OR51E2GPBAR1
SCHEMBL1331733 1.00 CYP19A1 (1.00) CYP19A1AKR1B10AKR1B1OR51E2GPBAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020264495-A1 COMPOSITIONS AND METHODS FOR TREATING CNS DISORDERS SAGE THERAPEUTICS, INC. (US) 2020-12-30 WO disclosed